Abstract
1. Neuropeptide Y caused a dose-dependent contraction and depolarization of the smooth muscle of the rat tail artery. 2. 30 nM-neuropeptide Y increased the contraction caused by either nerve-released noradrenaline or smooth muscle action potentials. 3. 30 nM-neuropeptide Y did not change the amplitude or rate of rise of the smooth muscle action potential. It did not change the amplitude of small excitatory junction potentials, suggesting that it did not affect neurotransmitter release. 4. 30 nM-neuropeptide Y increased the contraction caused by exogenous noradrenaline, 5-hydroxytryptamine and K in concentrations that gave submaximal contractions. It did not affect the response to higher concentrations that gave maximal or near-maximal contractions.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abel P. W., Urquilla P. R., Goto K., Westfall D. P., Robinson R. L., Fleming W. W. Chronic reserpine treatment alters sensitivity and membrane potential of the rabbit saphenous artery. J Pharmacol Exp Ther. 1981 May;217(2):430–439. [PubMed] [Google Scholar]
- Casteels R., Kitamura K., Kuriyama H., Suzuki H. Excitation-contraction coupling in the smooth muscle cells of the rabbit main pulmonary artery. J Physiol. 1977 Sep;271(1):63–79. doi: 10.1113/jphysiol.1977.sp011990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen M. L., Fuller R. W., Wiley K. S. Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle. J Pharmacol Exp Ther. 1981 Aug;218(2):421–425. [PubMed] [Google Scholar]
- Dahlöf C., Dahlöf P., Tatemoto K., Lundberg J. M. Neuropeptide Y (NPY) reduces field stimulation-evoked release of noradrenaline and enhances force of contraction in the rat portal vein. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):327–330. doi: 10.1007/BF00515562. [DOI] [PubMed] [Google Scholar]
- Edvinsson L., Ekblad E., Håkanson R., Wahlestedt C. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol. 1984 Oct;83(2):519–525. doi: 10.1111/j.1476-5381.1984.tb16516.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edvinsson L., Emson P., McCulloch J., Tatemoto K., Uddman R. Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ. Acta Physiol Scand. 1984 Oct;122(2):155–163. doi: 10.1111/j.1748-1716.1984.tb07493.x. [DOI] [PubMed] [Google Scholar]
- Ekblad E., Edvinsson L., Wahlestedt C., Uddman R., Håkanson R., Sundler F. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept. 1984 Apr;8(3):225–235. doi: 10.1016/0167-0115(84)90064-8. [DOI] [PubMed] [Google Scholar]
- Finkel A. S., Hirst G. D., Van Helden D. F. Some properties of excitatory junction currents recorded from submucosal arterioles of guinea-pig ileum. J Physiol. 1984 Jun;351:87–98. doi: 10.1113/jphysiol.1984.sp015234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fredholm B. B., Jansen I., Edvinsson L. Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. Acta Physiol Scand. 1985 Jul;124(3):467–469. doi: 10.1111/j.1748-1716.1985.tb07683.x. [DOI] [PubMed] [Google Scholar]
- Ginsborg B. L. Electrical changes in the membrane in junctional transmission. Biochim Biophys Acta. 1973 Nov 28;300(3):289–317. doi: 10.1016/0304-4157(73)90007-5. [DOI] [PubMed] [Google Scholar]
- Glover W. E. Increased sensitivity of rabbit ear artery to noradrenaline following perivascular nerve stimulation may be a response to neuropeptide Y released as cotransmitter. Clin Exp Pharmacol Physiol. 1985 May-Jun;12(3):227–230. doi: 10.1111/j.1440-1681.1985.tb02636.x. [DOI] [PubMed] [Google Scholar]
- Hirst G. D., Neild T. O. An analysis of excitatory junctional potentials recorded from arterioles. J Physiol. 1978 Jul;280:87–104. doi: 10.1113/jphysiol.1978.sp012374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirst G. D., Silverberg G. D., van Helden D. F. The action potential and underlying ionic currents in proximal rat middle cerebral arterioles. J Physiol. 1986 Feb;371:289–304. doi: 10.1113/jphysiol.1986.sp015975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lundberg J. M., Fried G., Pernow J., Theodorsson-Norheim E. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat. Acta Physiol Scand. 1986 Feb;126(2):231–238. doi: 10.1111/j.1748-1716.1986.tb07810.x. [DOI] [PubMed] [Google Scholar]
- Lundberg J. M., Pernow J., Tatemoto K., Dahlöf C. Pre- and postjunctional effects of NPY on sympathetic control of rat femoral artery. Acta Physiol Scand. 1985 Apr;123(4):511–513. doi: 10.1111/j.1748-1716.1985.tb07619.x. [DOI] [PubMed] [Google Scholar]
- Lundberg J. M., Stjarne L. Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens. Acta Physiol Scand. 1984 Mar;120(3):477–479. doi: 10.1111/j.1748-1716.1984.tb07410.x. [DOI] [PubMed] [Google Scholar]
- Lundberg J. M., Tatemoto K. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol Scand. 1982 Dec;116(4):393–402. doi: 10.1111/j.1748-1716.1982.tb07157.x. [DOI] [PubMed] [Google Scholar]
- Morris J. L., Gibbins I. L., Furness J. B., Costa M., Murphy R. Co-localization of neuropeptide Y, vasoactive intestinal polypeptide and dynorphin in non-noradrenergic axons of the guinea pig uterine artery. Neurosci Lett. 1985 Nov 20;62(1):31–37. doi: 10.1016/0304-3940(85)90280-0. [DOI] [PubMed] [Google Scholar]
- Mulvany M. J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977 Jul;41(1):19–26. doi: 10.1161/01.res.41.1.19. [DOI] [PubMed] [Google Scholar]
- Mulvany M. J., Nilsson H., Flatman J. A. Role of membrane potential in the response of rat small mesenteric arteries to exogenous noradrenaline stimulation. J Physiol. 1982 Nov;332:363–373. doi: 10.1113/jphysiol.1982.sp014418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakashima A., Angus J. A., Johnston C. I. Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria. Eur J Pharmacol. 1982 Jul 16;81(3):487–492. doi: 10.1016/0014-2999(82)90114-5. [DOI] [PubMed] [Google Scholar]
- Nasseri A., Barakeh J. F., Abel P. W., Minneman K. P. Reserpine-induced postjunctional supersensitivity in rat vas deferens and caudal artery without changes in alpha adrenergic receptors. J Pharmacol Exp Ther. 1985 Aug;234(2):350–357. [PubMed] [Google Scholar]
- Neild T. O., Zelcer E. Noradrenergic neuromuscular transmission with special reference to arterial smooth muscle. Prog Neurobiol. 1982;19(3):141–158. doi: 10.1016/0301-0082(82)90004-1. [DOI] [PubMed] [Google Scholar]
- Neild T., Kotecha N. Two-component responses to sympathetic nerve stimulation in the rat tail artery. Comp Biochem Physiol C. 1985;81(2):311–317. doi: 10.1016/0742-8413(85)90012-x. [DOI] [PubMed] [Google Scholar]
- Potter E. K. Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y? Neurosci Lett. 1985 Mar 15;54(2-3):117–121. doi: 10.1016/s0304-3940(85)80065-3. [DOI] [PubMed] [Google Scholar]
- Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 1982 Apr 15;296(5858):659–660. doi: 10.1038/296659a0. [DOI] [PubMed] [Google Scholar]
- Uddman R., Ekblad E., Edvinsson L., Håkanson R., Sundler F. Neuropeptide Y-like immunoreactivity in perivascular nerve fibres of the guinea-pig. Regul Pept. 1985 Mar;10(2-3):243–257. doi: 10.1016/0167-0115(85)90019-9. [DOI] [PubMed] [Google Scholar]
- Vanhoutee P. M., Verbeuren T. J. Inhibition by acetylcholine of the norepinephrine release evoked by potassium in canine saphenous veins. Circ Res. 1976 Aug;39(2):263–269. doi: 10.1161/01.res.39.2.263. [DOI] [PubMed] [Google Scholar]